You have 9 free searches left this month | for more free features.

Eye Diseases, Hereditary

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

Recruiting
  • Retinitis Pigmentosa
  • +4 more
    • San Francisco, California
    • +4 more
    Oct 5, 2022

    Leber Congenital Amaurosis 10, Inherited Retinal Dystrophies, Eye Diseases, Hereditary Trial in United States (EDIT-101)

    Active, not recruiting
    • Leber Congenital Amaurosis 10
    • +6 more
    • Miami, Florida
    • +4 more
    Dec 2, 2022

    Natural History Study of CEP290-Related Retinal Degeneration

    Completed
    • Blindness
    • +7 more
      • Miami, Florida
      • +6 more
      May 18, 2022

      Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham

      Active, not recruiting
      • Retinitis Pigmentosa
      • +6 more
      • Gene Therapy Product-vMCO-010
      • Sham Injection
      • Beverly Hills, California
      • +6 more
      Jul 13, 2022

      Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Dallas, Madison, London (QR-421a, Sham-procedure)

      Active, not recruiting
      • Retinitis Pigmentosa
      • +7 more
      • Dallas, Texas
      • +2 more
      Apr 21, 2022

      Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)

      Recruiting
      • Graves Ophthalmopathy
      • +8 more
      • Doxycycline hyclate
      • Placebo
      • Guangzhou, Guangdong, China
        Zhongshan Ophthalmic Center
      Nov 16, 2021

      Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Iowa City, Philadelphia, Ghent (QR-110)

      Active, not recruiting
      • Leber Congenital Amaurosis 10
      • +9 more
      • Iowa City, Iowa
      • +2 more
      Feb 8, 2022

      PCDH15-Related Retinal Degeneration in Usher Syndrome 1F

      Recruiting
      • Retinal Degeneration
      • +2 more
        • San Francisco, California
        • +7 more
        Jan 12, 2022

        Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)

        Recruiting
        • Retinitis Pigmentosa
        • +7 more
        • San Diego, California
        • +14 more
        Jul 29, 2022

        Stickler Syndrome Trial in Paris (Encircling scleral buckle surgical procedure)

        Not yet recruiting
        • Stickler Syndrome
        • Encircling scleral buckle surgical procedure
        • Paris, France
          Hôpital Cochin
        Apr 6, 2022

        Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose

        Completed
        • Retinitis Pigmentosa
        • +7 more
        • QR-421a
        • Sham-procedure (dose cohort 1&2 only)
        • Boston, Massachusetts
        • +6 more
        Apr 19, 2022

        Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Worldwide (sepofarsen, Sham)

        Active, not recruiting
        • Leber Congenital Amaurosis 10
        • +9 more
        • Iowa City, Iowa
        • +13 more
        Mar 2, 2022

        Ophthalmological Disorder, Corneal Dystrophy, Treatment Trial in Alicante (Implantation, Lipoaspiration)

        Recruiting
        • Ophthalmological Disorder
        • +4 more
        • Implantation
        • Lipoaspiration
        • Alicante, Spain
          Jorge L. Alio
        Oct 18, 2022

        Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Sham)

        Completed
        • Leber Hereditary Optic Neuropathy
        • GS010
        • Sham
        • Pasadena, California
        • +6 more
        Jul 25, 2022

        Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Placebo)

        Active, not recruiting
        • Leber Hereditary Optic Neuropathy
        • GS010
        • Placebo
        • Pasadena, California
        • +12 more
        Aug 2, 2022

        Leber's Hereditary Optic Neuropathy Trial in Pasadena (elamipretide (MTP-131) 1% topical ophthalmic solution, Vehicle topical

        Completed
        • Leber's Hereditary Optic Neuropathy
        • elamipretide (MTP-131) 1% topical ophthalmic solution
        • Vehicle topical ophthalmic solution
        • Pasadena, California
          Doheny Eye Center
        Nov 29, 2021

        Bietti's Crystalline Dystrophy Trial in China (ZVS101e)

        Recruiting
        • Bietti's Crystalline Dystrophy
        • Beijing, Beijing, China
        • +3 more
        Apr 16, 2023

        Fuchs Endothelial Corneal Dystrophy, FECD3, Corneal Diseases Trial in London (QR-504a)

        Withdrawn
        • Fuchs Endothelial Corneal Dystrophy
        • +4 more
        • London, United Kingdom
          Moorfields Eye Hospital, NIHR Clinical Research Facility
        May 5, 2022

        Retinitis Pigmentosa, Leber's Hereditary Optic Neuropathy, Stargardt Disease Trial in Paris (Dynamic pupillometry sessions)

        Completed
        • Retinitis Pigmentosa
        • +2 more
        • Dynamic pupillometry sessions
        • Paris, France
          Centre Hospitalier National D'Ophtalùmologie des Quinze-Vingts
        May 28, 2021

        Strabismus, Congenital Cranial Dysinnervation Disorders, and

        Recruiting
        • Congenital Fibrosis of Extraocular Muscles
        • +25 more
          • Boston, Massachusetts
            Boston Children's Hospital
          Sep 23, 2022

          Leber's Hereditary Optic Neuropathy Trial in Miami (injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),, injection of scAAV2-P1ND4v2

          Active, not recruiting
          • Leber's Hereditary Optic Neuropathy
          • injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),
          • +3 more
          • Miami, Florida
            Bascom Palmer Eye Institute, University of Miami
          Jul 1, 2021

          Disease and Visual Disability on Quality of Life and Loss of

          Recruiting
          • Leber's Hereditary Optic Neuropathy (LHON)
            • Orléans, France
              Argo Sante
            Sep 22, 2022

            Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

            Not yet recruiting
            • Leber Hereditary Optic Neuropathy (LHON)
            • NFS-02 Injection
            • (no location specified)
            Apr 6, 2023

            Leber Hereditary Optic Neuropathy Trial in Worldwide (Patient-reported outcomes (PROs))

            Completed
            • Leber Hereditary Optic Neuropathy
            • Patient-reported outcomes (PROs)
            • Pasadena, California
            • +10 more
            Feb 3, 2021

            Trial

            Not yet recruiting
            • Leber Hereditary Optic Neuropathy (LHON)
            • NR082 Injection
            • Injection needle
            • (no location specified)
            Jan 30, 2023